A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients. [electronic resource]
- Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Jun 2016
- 7295-303 p. digital
Publication Type: Journal Article
1423-0380
10.1007/s13277-015-4543-3 doi
Adenocarcinoma--drug therapy Aged Antibodies, Monoclonal--therapeutic use Antineoplastic Agents--therapeutic use Antineoplastic Combined Chemotherapy Protocols--administration & dosage Camptothecin--administration & dosage Cetuximab--administration & dosage Codon--genetics Colorectal Neoplasms--drug therapy Disease-Free Survival Drug Resistance, Neoplasm--genetics ErbB Receptors--antagonists & inhibitors Female Fluorouracil--administration & dosage Genes, erbB-1 Genes, ras Humans Irinotecan Leucovorin--administration & dosage Male Middle Aged Neoplasm Proteins--antagonists & inhibitors Panitumumab Polymorphism, Single Nucleotide Protein Kinase Inhibitors--therapeutic use Proto-Oncogene Proteins p21(ras)--genetics Retrospective Studies Treatment Outcome